Embecta (EMBC) Return on Capital Employed (2021 - 2026)
Embecta recorded quarterly Return on Capital Employed of 33.63% in Q1 2026, down 4.48% quarter-over-quarter from 35.21% in Q4 2025, and up 1379.0% year-over-year from 2.27% in Q1 2025.
Embecta's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 33.63% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 1379.0% year-over-year to 33.63%; the TTM figure through Mar 2026 stood at 33.63% (up 1379.0% YoY), while the FY2025 annual figure was 26.13%, up 708.0% from the prior year.
- Return on Capital Employed came in at 33.63% for Q1 2026 at Embecta, down from 35.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 73.97% in Q1 2022 to a low of 16.32% in Q4 2024.
- A 5-year average of 30.63% and a median of 25.18% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 4577 bps in 2023 and soared 1889 bps in 2025, its largest moves.
- Embecta's Return on Capital Employed stood at 36.53% in 2022, then slumped by 45 bps to 20.03% in 2023, then slipped by 19 bps to 16.32% in 2024, then surged by 116 bps to 35.21% in 2025, then dropped by 4 bps to 33.63% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 33.63%, 35.21%, and 28.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | 33.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | 28.07% |
| Jun 30, 2025 | 24.54% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 18.48% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 18.01% |
| Dec 31, 2023 | 20.03% |
| Sep 30, 2023 | 25.18% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 28.20% |
| Dec 31, 2022 | 36.53% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 60.27% |
| Mar 31, 2022 | 73.97% |
| Dec 31, 2021 | 80.10% |